Tanhaji, Hajina A.
HRN: 14-25-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2024
CEFTRIAXONE 1G (VIAL)
03/29/2024
04/05/2024
IV
OD
2g
UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes